Drug Profile
R 1068
Latest Information Update: 12 May 2004
Price :
$50
*
At a glance
- Originator Roche
- Class Antiemetics
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 12 May 2004 Discontinued - Phase-I for Emesis in Switzerland (unspecified route)
- 05 Feb 2003 Phase-I clinical trials in Emesis in Switzerland (unspecified route)